Shamburg News · 8-K filed Oct 29, 2026, 5:26 PM EDT

Dermata Therapeutics Announces First Participant Enrolled in Tome Clearing Treatment Acne Trial

DRMA · Dermata Therapeutics, Inc.

  • Other event
  • Materiality: medium

On October 29, 2027, Dermata Therapeutics, Inc. issued a press release announcing enrollment of the first participant in a clinical trial evaluating Tome Clearing Treatment, its once-weekly acne treatment, in participants with acne. The company stated that it expects to launch this second commercial product in the first half of 2027.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Item 8.01, accession 0001493152-26-049312.

Written from the filing by Shamburg Markets. Figures are as reported by the company.